Abstract:OBJECTIVE: RNA interference (RNAi) refers to the phenomenon of sequence‐specific degradation of homologous mRNA induced by double‐stranded RNA. It has been successfully utilized to down‐regulate endogenous gene expression or suppress the replication of various pathogens in mammalian cells. In this study, the effect of vector‐based small interfering RNA (siRNA) promoted by pSilencer2.0‐U6 inhibit hepatitis B virus (HBV) replication in cell culture was evaluated. METHODS: Three fragments of short nucleic acids, respectively, targeting on S, X and C region of HBV genome were inserted into pSilencer vectors after they were annealed with their partly antisense strands. The recombination plasmids were pS, pX and pC. These expression plasmids were transfected into HepG2‐N10 cells, a cell line which stably expresses hepatitis B virus surface antigen (HBsAg), hepatitis B virus e antigen (HBeAg) and adw2 subtype Dane particles. The effect of RNAi was evaluated from the changes of DNA, RNA and protein levels. Viral antigens were measured by ELISA. Viral mRNA was analyzed by RT‐PCR. The covalent closed circular DNA and genome DNA of HBV secreted into the culture media were measured by quantitative real‐time PCR. Analysis of variance was performed for the results. RESULTS: Vector‐based RNA interference could potently reduce HBsAg (pS vs pN: 47%, pX vs pN: 30%, and pC vs pN: 25%, P < 0.001) and HBeAg (pX vs pN: 57% and pC vs pN: 66%, P < 0.001) expression in cell culture. Furthermore, RT‐PCR analysis showed that viral mRNAs were effectively degraded, thus eliminating the messengers for protein expression as well as templates for reverse transcription (pS and pC vs pN, P < 0.001; pX vs pN, P = 0.003). Quantitative real‐time PCR analysis of HBV DNA revealed that vector‐based RNA interference can inhibit HBV replication efficiently (pS, pX and pC vs pN, P < 0.001). CONCLUSIONS: Our results indicate that RNAi can inhibit HBV gene expression and replication, and it might have the potential to revolutionize the treatment of HBV.

Inhibition of Hepatitis B Virus Replication by Various RNAi Constructs and Their Pharmacodynamic Properties

Inhibition of Hepatitis B Virus Gene Expression by Single and Dual Small Interfering RNA Treatment

Effective Inhibition of Hepatitis B Virus Replication by Small Interfering RNAs Expressed from Human Foamy Virus Vectors.

RNA Interference inhibits Hepatitis B Virus of different genotypes in Vitro and in Vivo

INHIBITION OF HEPATITIS B VIRUS BY COMBINED Sirnas IN VITRO

RNA Interference Inhibits Hepatitis B Virus Gene Expression and Replication in HepG2-N10 Cells

Inhibition of Hepatitis B Virus Replication by Recombinant Small Interfering RNAs.

Stable Inhibition of Hepatitis B Virus Expression and Replication by Expressed Sirna

Combination of Small Interfering RNAs Mediates Greater Inhibition of Human Hepatitis B Virus Replication and Antigen Expression

[Inhibition of Hepatitis B Virus Replication and Expression by RNA Interference in Vivo].

Long-term RNA interference and its application to hepatitis B virus

Inhibition of Hepatitis B Virus Replication by Stably Expressed Shrna

Inhibition of hepatitis viral replication by siRNA.

RNAi for Treating Hepatitis B Viral Infection

[Inhibition of Hepatitis B Virus Replication by RNA Interference in Vitro].

Sirna-Mediated Inhibition of Hbv Replication and Expression

The short hairpin RNA driven by polymerase II suppresses both wild-type and lamivudine-resistant hepatitis B virus strains.

Simultaneously Inhibition of Hiv and Hbv Replication Through A Dual Small Interfering Rna Expression System

[Inhibition of HBsAg and HBeAg Secretion by RNA Interference of the Polymerase Gene Sequence of Hepatitis B Virus: an Experimental Study].

Inhibition of Hepatitis C Virus Replication and Expression by Small Interfering Rna Targeting Host Cellular Genes

Inhibition of Hepatitis B Virus Replication by pRNA-escorted siRNA